Table of Content

1 Recombinant DNA Vaccine Market Overview
1.1 Product Overview and Scope of Recombinant DNA Vaccine
1.2 Recombinant DNA Vaccine Segment by Type
1.2.1 Global Recombinant DNA Vaccine Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Recombinant Protein Vaccine
1.2.3 Gene-Based Vaccine
1.3 Recombinant DNA Vaccine Segment by Application
1.3.1 Recombinant DNA Vaccine Sales Comparison by Application: (2021-2027)
1.3.2 Human
1.3.3 Animal
1.4 Global Recombinant DNA Vaccine Market Size Estimates and Forecasts
1.4.1 Global Recombinant DNA Vaccine Revenue 2016-2027
1.4.2 Global Recombinant DNA Vaccine Sales 2016-2027
1.4.3 Recombinant DNA Vaccine Market Size by Region: 2016 Versus 2021 Versus 2027

2 Recombinant DNA Vaccine Market Competition by Manufacturers
2.1 Global Recombinant DNA Vaccine Sales Market Share by Manufacturers (2016-2021)
2.2 Global Recombinant DNA Vaccine Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Recombinant DNA Vaccine Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Recombinant DNA Vaccine Manufacturing Sites, Area Served, Product Type
2.5 Recombinant DNA Vaccine Market Competitive Situation and Trends
2.5.1 Recombinant DNA Vaccine Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Recombinant DNA Vaccine Players Market Share by Revenue
2.5.3 Global Recombinant DNA Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Recombinant DNA Vaccine Retrospective Market Scenario by Region
3.1 Global Recombinant DNA Vaccine Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Recombinant DNA Vaccine Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Recombinant DNA Vaccine Market Facts & Figures by Country
3.3.1 North America Recombinant DNA Vaccine Sales by Country
3.3.2 North America Recombinant DNA Vaccine Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Recombinant DNA Vaccine Market Facts & Figures by Country
3.4.1 Europe Recombinant DNA Vaccine Sales by Country
3.4.2 Europe Recombinant DNA Vaccine Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Recombinant DNA Vaccine Market Facts & Figures by Region
3.5.1 Asia Pacific Recombinant DNA Vaccine Sales by Region
3.5.2 Asia Pacific Recombinant DNA Vaccine Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Recombinant DNA Vaccine Market Facts & Figures by Country
3.6.1 Latin America Recombinant DNA Vaccine Sales by Country
3.6.2 Latin America Recombinant DNA Vaccine Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Recombinant DNA Vaccine Market Facts & Figures by Country
3.7.1 Middle East and Africa Recombinant DNA Vaccine Sales by Country
3.7.2 Middle East and Africa Recombinant DNA Vaccine Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Recombinant DNA Vaccine Historic Market Analysis by Type
4.1 Global Recombinant DNA Vaccine Sales Market Share by Type (2016-2021)
4.2 Global Recombinant DNA Vaccine Revenue Market Share by Type (2016-2021)
4.3 Global Recombinant DNA Vaccine Price by Type (2016-2021)

5 Global Recombinant DNA Vaccine Historic Market Analysis by Application
5.1 Global Recombinant DNA Vaccine Sales Market Share by Application (2016-2021)
5.2 Global Recombinant DNA Vaccine Revenue Market Share by Application (2016-2021)
5.3 Global Recombinant DNA Vaccine Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Recombinant DNA Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Merck Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 GSK
6.2.1 GSK Corporation Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Recombinant DNA Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.2.4 GSK Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Corporation Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi Recombinant DNA Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Sanofi Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 Zoties
6.4.1 Zoties Corporation Information
6.4.2 Zoties Description and Business Overview
6.4.3 Zoties Recombinant DNA Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Zoties Product Portfolio
6.4.5 Zoties Recent Developments/Updates
6.5 Elanco
6.5.1 Elanco Corporation Information
6.5.2 Elanco Description and Business Overview
6.5.3 Elanco Recombinant DNA Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Elanco Product Portfolio
6.5.5 Elanco Recent Developments/Updates
6.6 Boehringer-Ingelheim
6.6.1 Boehringer-Ingelheim Corporation Information
6.6.2 Boehringer-Ingelheim Description and Business Overview
6.6.3 Boehringer-Ingelheim Recombinant DNA Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Boehringer-Ingelheim Product Portfolio
6.6.5 Boehringer-Ingelheim Recent Developments/Updates
6.7 Indian Immunologicals
6.6.1 Indian Immunologicals Corporation Information
6.6.2 Indian Immunologicals Description and Business Overview
6.6.3 Indian Immunologicals Recombinant DNA Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Indian Immunologicals Product Portfolio
6.7.5 Indian Immunologicals Recent Developments/Updates
6.8 Plumbline Life Sciences
6.8.1 Plumbline Life Sciences Corporation Information
6.8.2 Plumbline Life Sciences Description and Business Overview
6.8.3 Plumbline Life Sciences Recombinant DNA Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Plumbline Life Sciences Product Portfolio
6.8.5 Plumbline Life Sciences Recent Developments/Updates

7 Recombinant DNA Vaccine Manufacturing Cost Analysis
7.1 Recombinant DNA Vaccine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Recombinant DNA Vaccine
7.4 Recombinant DNA Vaccine Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Recombinant DNA Vaccine Distributors List
8.3 Recombinant DNA Vaccine Customers

9 Recombinant DNA Vaccine Market Dynamics
9.1 Recombinant DNA Vaccine Industry Trends
9.2 Recombinant DNA Vaccine Growth Drivers
9.3 Recombinant DNA Vaccine Market Challenges
9.4 Recombinant DNA Vaccine Market Restraints

10 Global Market Forecast
10.1 Recombinant DNA Vaccine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Recombinant DNA Vaccine by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Recombinant DNA Vaccine by Type (2022-2027)
10.2 Recombinant DNA Vaccine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Recombinant DNA Vaccine by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Recombinant DNA Vaccine by Application (2022-2027)
10.3 Recombinant DNA Vaccine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Recombinant DNA Vaccine by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Recombinant DNA Vaccine by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Recombinant DNA Vaccine Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Recombinant DNA Vaccine Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Recombinant DNA Vaccine Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Recombinant DNA Vaccine Covered in This Study
Table 5. Global Recombinant DNA Vaccine Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Recombinant DNA Vaccine Sales Share by Manufacturers (2016-2021)
Table 7. Global Recombinant DNA Vaccine Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Recombinant DNA Vaccine Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Recombinant DNA Vaccine Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Recombinant DNA Vaccine Manufacturing Sites and Area Served
Table 11. Manufacturers Recombinant DNA Vaccine Product Type
Table 12. Global Recombinant DNA Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Recombinant DNA Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant DNA Vaccine as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Recombinant DNA Vaccine Sales by Region (2016-2021) & (K Units)
Table 16. Global Recombinant DNA Vaccine Sales Market Share by Region (2016-2021)
Table 17. Global Recombinant DNA Vaccine Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Recombinant DNA Vaccine Sales by Country (2016-2021) & (K Units)
Table 19. North America Recombinant DNA Vaccine Sales Market Share by Country (2016-2021)
Table 20. North America Recombinant DNA Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Recombinant DNA Vaccine Revenue Market Share by Country (2016-2021)
Table 22. Europe Recombinant DNA Vaccine Sales by Country (2016-2021) & (K Units)
Table 23. Europe Recombinant DNA Vaccine Sales Market Share by Country (2016-2021)
Table 24. Europe Recombinant DNA Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Recombinant DNA Vaccine Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Recombinant DNA Vaccine Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Recombinant DNA Vaccine Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Recombinant DNA Vaccine Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Recombinant DNA Vaccine Revenue Market Share by Region (2016-2021)
Table 30. Latin America Recombinant DNA Vaccine Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Recombinant DNA Vaccine Sales Market Share by Country (2016-2021)
Table 32. Latin America Recombinant DNA Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Recombinant DNA Vaccine Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Recombinant DNA Vaccine Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Recombinant DNA Vaccine Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Recombinant DNA Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Recombinant DNA Vaccine Revenue Market Share by Country (2016-2021)
Table 38. Global Recombinant DNA Vaccine Sales (K Units) by Type (2016-2021)
Table 39. Global Recombinant DNA Vaccine Sales Market Share by Type (2016-2021)
Table 40. Global Recombinant DNA Vaccine Revenue (Million US$) by Type (2016-2021)
Table 41. Global Recombinant DNA Vaccine Revenue Share by Type (2016-2021)
Table 42. Global Recombinant DNA Vaccine Price (US$/Unit) by Type (2016-2021)
Table 43. Global Recombinant DNA Vaccine Sales (K Units) by Application (2016-2021)
Table 44. Global Recombinant DNA Vaccine Sales Market Share by Application (2016-2021)
Table 45. Global Recombinant DNA Vaccine Revenue (Million US$) by Application (2016-2021)
Table 46. Global Recombinant DNA Vaccine Revenue Share by Application (2016-2021)
Table 47. Global Recombinant DNA Vaccine Price (US$/Unit) by Application (2016-2021)
Table 48. Merck Corporation Information
Table 49. Merck Description and Business Overview
Table 50. Merck Recombinant DNA Vaccine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. Merck Recombinant DNA Vaccine Product
Table 52. Merck Recent Developments/Updates
Table 53. GSK Corporation Information
Table 54. GSK Description and Business Overview
Table 55. GSK Recombinant DNA Vaccine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. GSK Recombinant DNA Vaccine Product
Table 57. GSK Recent Developments/Updates
Table 58. Sanofi Corporation Information
Table 59. Sanofi Description and Business Overview
Table 60. Sanofi Recombinant DNA Vaccine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. Sanofi Recombinant DNA Vaccine Product
Table 62. Sanofi Recent Developments/Updates
Table 63. Zoties Corporation Information
Table 64. Zoties Description and Business Overview
Table 65. Zoties Recombinant DNA Vaccine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. Zoties Recombinant DNA Vaccine Product
Table 67. Zoties Recent Developments/Updates
Table 68. Elanco Corporation Information
Table 69. Elanco Description and Business Overview
Table 70. Elanco Recombinant DNA Vaccine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 71. Elanco Recombinant DNA Vaccine Product
Table 72. Elanco Recent Developments/Updates
Table 73. Boehringer-Ingelheim Corporation Information
Table 74. Boehringer-Ingelheim Description and Business Overview
Table 75. Boehringer-Ingelheim Recombinant DNA Vaccine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 76. Boehringer-Ingelheim Recombinant DNA Vaccine Product
Table 77. Boehringer-Ingelheim Recent Developments/Updates
Table 78. Indian Immunologicals Corporation Information
Table 79. Indian Immunologicals Description and Business Overview
Table 80. Indian Immunologicals Recombinant DNA Vaccine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 81. Indian Immunologicals Recombinant DNA Vaccine Product
Table 82. Indian Immunologicals Recent Developments/Updates
Table 83. Plumbline Life Sciences Corporation Information
Table 84. Plumbline Life Sciences Description and Business Overview
Table 85. Plumbline Life Sciences Recombinant DNA Vaccine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 86. Plumbline Life Sciences Recombinant DNA Vaccine Product
Table 87. Plumbline Life Sciences Recent Developments/Updates
Table 88. Production Base and Market Concentration Rate of Raw Material
Table 89. Key Suppliers of Raw Materials
Table 90. Recombinant DNA Vaccine Distributors List
Table 91. Recombinant DNA Vaccine Customers List
Table 92. Recombinant DNA Vaccine Market Trends
Table 93. Recombinant DNA Vaccine Growth Drivers
Table 94. Recombinant DNA Vaccine Market Restraints
Table 95. Global Recombinant DNA Vaccine Sales Forecast by Type (2022-2027) & (K Units)
Table 96. Global Recombinant DNA Vaccine Sales Market Share Forecast by Type (2022-2027)
Table 97. Global Recombinant DNA Vaccine Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 98. Global Recombinant DNA Vaccine Revenue Market Share Forecast by Type (2022-2027)
Table 99. Global Recombinant DNA Vaccine Sales Forecast by Application (2022-2027) & (K Units)
Table 100. Global Recombinant DNA Vaccine Sales Market Share Forecast by Application (2022-2027)
Table 101. Global Recombinant DNA Vaccine Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 102. Global Recombinant DNA Vaccine Revenue Market Share Forecast by Application (2022-2027)
Table 103. Global Recombinant DNA Vaccine Sales Forecast by Region (2022-2027) & (K Units)
Table 104. Global Recombinant DNA Vaccine Sales Market Share Forecast by Region (2022-2027)
Table 105. Global Recombinant DNA Vaccine Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 106. Global Recombinant DNA Vaccine Revenue Market Share Forecast by Region (2022-2027)
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Recombinant DNA Vaccine
Figure 2. Global Recombinant DNA Vaccine Market Share by Type in 2020 & 2027
Figure 3. Recombinant Protein Vaccine Product Picture
Figure 4. Gene-Based Vaccine Product Picture
Figure 5. Global Recombinant DNA Vaccine Market Share by Application in 2020 & 2027
Figure 6. Human
Figure 7. Animal
Figure 8. Global Recombinant DNA Vaccine Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Recombinant DNA Vaccine Market Size 2016-2027 (US$ Million)
Figure 10. Global Recombinant DNA Vaccine Sales 2016-2027 (K Units)
Figure 11. Global Recombinant DNA Vaccine Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 12. Recombinant DNA Vaccine Sales Share by Manufacturers in 2020
Figure 13. Global Recombinant DNA Vaccine Revenue Share by Manufacturers in 2020
Figure 14. The Global 5 and 10 Largest Recombinant DNA Vaccine Players: Market Share by Revenue in 2020
Figure 15. Recombinant DNA Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 16. Global Recombinant DNA Vaccine Sales Market Share by Region (2016-2021)
Figure 17. Global Recombinant DNA Vaccine Sales Market Share by Region in 2020
Figure 18. Global Recombinant DNA Vaccine Revenue Market Share by Region (2016-2021)
Figure 19. Global Recombinant DNA Vaccine Revenue Market Share by Region in 2020
Figure 20. U.S. Recombinant DNA Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 21. Canada Recombinant DNA Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Germany Recombinant DNA Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. France Recombinant DNA Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. U.K. Recombinant DNA Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Italy Recombinant DNA Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Russia Recombinant DNA Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. China Recombinant DNA Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Japan Recombinant DNA Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. South Korea Recombinant DNA Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. India Recombinant DNA Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Australia Recombinant DNA Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Taiwan Recombinant DNA Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Indonesia Recombinant DNA Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Thailand Recombinant DNA Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Malaysia Recombinant DNA Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Philippines Recombinant DNA Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Vietnam Recombinant DNA Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Mexico Recombinant DNA Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Brazil Recombinant DNA Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Argentina Recombinant DNA Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Turkey Recombinant DNA Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Saudi Arabia Recombinant DNA Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. UAE Recombinant DNA Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Sales Market Share of Recombinant DNA Vaccine by Type (2016-2021)
Figure 45. Sales Market Share of Recombinant DNA Vaccine by Application (2016-2021)
Figure 46. Sales Market Share of Recombinant DNA Vaccine by Application in 2020
Figure 47. Revenue Share of Recombinant DNA Vaccine by Application (2016-2021)
Figure 48. Revenue Share of Recombinant DNA Vaccine by Application in 2020
Figure 49. Manufacturing Cost Structure of Recombinant DNA Vaccine
Figure 50. Manufacturing Process Analysis of Recombinant DNA Vaccine
Figure 51. Recombinant DNA Vaccine Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed